Home › Funds › Citadel Advisors › STRO
Citadel Advisors position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)101.97K sh
Reported value held$3.39M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 669.64K | $12.65M | New |
| Q4 2021 | 596.77K | $8.88M | Reduce |
| Q1 2022 | 357.85K | $2.94M | Reduce |
| Q2 2022 | 648.00K | $3.38M | Add |
| Q3 2022 | 302.09K | $1.68M | Reduce |
| Q4 2022 | 125.10K | $1.01M | Reduce |
| Q1 2023 | 330.77K | $1.53M | Add |
| Q2 2023 | 32.53K | $151.26K | Reduce |
| Q3 2023 | 50.69K | $175.89K | Add |
| Q4 2023 | 134.72K | $577.97K | Add |
| Q1 2024 | 350.94K | $1.98M | Add |
| Q2 2024 | 1.62M | $4.76M | Add |
| Q3 2024 | 2.14M | $7.40M | Add |
| Q4 2024 | 2.48M | $4.55M | Add |
| Q1 2025 | 180.53K | $117.45K | Reduce |
| Q2 2025 | 17.80K | $12.71K | Reduce |
| Q4 2025 | 32.09K | $371.22K | New |
| Q1 2026 | 142.34K | $3.55M | Add |
| Q2 2026 | 101.97K | $3.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026